Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
Open Access
- 7 April 2014
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 13 (1) , 138
Abstract
Successful programmatic use of anti-malarials faces challenges that are not covered by standard drug development processes. The development of appropriate pragmatic dosing regimens for low-resource settings or community-based use is not formally regulated, even though these may alter factors which can substantially affect individual patient and population level outcome, such as drug exposure, patient adherence and the spread of drug resistance and can affect a drug’s reputation and its eventual therapeutic lifespan.Keywords
This publication has 53 references indexed in Scilit:
- Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical developmentMalaria Journal, 2012
- Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaMalaria Journal, 2012
- Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, EthiopiaMalaria Journal, 2011
- Development, Evaluation, and Application of an In Silico Model for Antimalarial Drug Treatment and FailureAntimicrobial Agents and Chemotherapy, 2011
- Intrahost modeling of artemisinin resistance in Plasmodium falciparumProceedings of the National Academy of Sciences, 2010
- Population Pharmacokinetics and Pharmacodynamics of Artemether and Lumefantrine during Combination Treatment in Children with Uncomplicated Falciparum Malaria in TanzaniaAntimicrobial Agents and Chemotherapy, 2010
- Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in TanzaniaMalaria Journal, 2010
- A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west NigeriaBMC Health Services Research, 2008
- Population Pharmacokinetics of Piperaquine after Two Different Treatment Regimens with Dihydroartemisinin-Piperaquine in Patients with Plasmodium falciparum Malaria in ThailandAntimicrobial Agents and Chemotherapy, 2008
- Pharmacokinetics and Efficacy of Piperaquine and Chloroquine in Melanesian Children with Uncomplicated MalariaAntimicrobial Agents and Chemotherapy, 2008